Joseph D. Tobias

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Joseph D. Tobias sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).

21 total trials none currently recruiting 17 completed top decile by trial count

Joseph D. Tobias: 21 sponsored US clinical trials, none currently recruiting.

Joseph D. Tobias sponsors 21 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 17 completed. The most-studied condition in this pipeline is Surgery, with 3 trials.

Top-decile sponsor footprint

Joseph D. Tobias ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

17 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

21 total, page 1 of 1

ACTIVE NOT RECRUITING NA

TetraGraph in Rocuronium Infusions

NCT06472284

ACTIVE NOT RECRUITING NA

TOF Monitoring Using the TetraGraph in Patients Less Than 1 Year of Age

NCT06458023

NOT YET RECRUITING NA

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph

NCT07133412

NOT YET RECRUITING

Differences in Radial and Ulnar Artery Size in Young Children

NCT07558694

COMPLETED NA

Feasibility of Obtaining Pulse Oximetry Readings from the Oropharynx

NCT05690633

COMPLETED NA

Tetragraph® Monitor: Tolerance of Preoperative Placement

NCT05964166

COMPLETED NA

Train-of-four Monitoring Using the Tetragraph

NCT04475250

COMPLETED NA

Accuracy of the NICCI™ Monitor in Children and Adolescents

NCT04373746

COMPLETED

Heart Rate Changes Following the Administration of Sugammadex

NCT03294018

COMPLETED NA

VL vs DL in Inexperienced Users: a Pediatric Manikin Study

NCT02991820

COMPLETED

Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country

NCT02704351

COMPLETED

Changes in Cerebral Oxygenation Based on Intraoperative Ventilation Strategy

NCT02651103

COMPLETED

Correlation of Arterial and Venous Lactate and Base Deficit Values

NCT02888431

COMPLETED

Intracuff Pressure During One-lung Ventilation in Infants and Children

NCT02424487

COMPLETED

Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

NCT02207855

COMPLETED

New Devices to Measure the Intracuff Pressure

NCT02202798

COMPLETED

Bradycardia Following Intraoperative Administration of Dexmedetomidine

NCT01917097

COMPLETED

Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

NCT02049320

COMPLETED

Modes of Ventilation During Laparoscopic Bariatric Surgery

NCT01890564

COMPLETED NA

CNAP Accuracy in the Bariatric Surgery Population

NCT01896206

COMPLETED

Perioperative Antibiotic Choices for Surgical Prophylaxis in Penicillin-allergic Pediatric Patients

NCT02036840

How the Joseph D. Tobias archive is shaped

21 indexed studies, none listed as recruiting (0% open); 17 completed (81%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Surgery (3 trials), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Joseph D. Tobias: archived-pipeline peers nationwide

Peers matched on 21 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Joseph D. Tobias sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0510152025 0%2%4%6%8%10% Total trials Recruiting share Joseph D. TobiasAEterna ZentarisAmphastar PharmaceuticalsApellis PharmaceuticalsArray Biopharma, now a wholly owned subsidiary of Pfizer10xBio22nd Century Group23andMe3-C Institute for Social Development
Joseph D. Tobias sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Joseph D. Tobias sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 21 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Joseph D. Tobias page

21 registered trials is a research-attention snapshot, not an endorsement of Joseph D. Tobias or any single study.

  • None of Joseph D. Tobias's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Surgery is the condition Joseph D. Tobias studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Surgery trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Joseph D. Tobias pipeline card: 21 registered trials from official public datasets.Report a data error.